Academic History
Erin Parry, MD, PhD, is a Physician at Dana-Farber Cancer Institute, Boston, MA, and an Instructor in Medicine at Harvard Medical School, Boston, MA.
Dr Parry completed her medical degree at Johns Hopkins University School of Medicine, Baltimore, MD, followed by a Residency in Internal Medicine at the same institution and a Fellowship in Medical Oncology at Dana-Farber/Partners CancerCare. She is Board Certified in Internal Medicine and Medical Oncology.
Her research focuses on the transformation of indolent lymphoma to aggressive lymphoma and mechanisms of immune evasion in lymphoma and chronic lymphocytic leukemia (CLL).
Speaking on the genomics and treatment of Richter’s transformation
Dr Parry speaks on the genomics of Richter’s transformation, focusing on its diagnosis and evolution from CLL. She also touches on treatment strategies under investigation for RT.
